Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...
Investing in pharmaceutical stocks offers dividends and growth from a $2 trillion market. Eli Lilly leads in market cap, with promising drugs in obesity and diabetes treatment. Pfizer, despite ...
Forbes contributors publish independent expert analyses and insights. I provide insider insights into the Midwest's startup ecosystem. Retail is undergoing a transformative period, thanks to the ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results